Charles Remsberg - ReWalk Robotics Chief Officer
| LFWD Stock | 0.61 0.01 1.61% |
Executive
Charles Remsberg is Chief Officer of ReWalk Robotics
| Age | 63 |
| Address | 3 Hatnufa Street, Yokneam Illit, Israel, 2069203 |
| Phone | 972 4 959 0123 |
| Web | https://golifeward.com |
ReWalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.3229) % which means that it has lost $0.3229 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2795) %, meaning that it created substantial loss on money invested by shareholders. ReWalk Robotics' management efficiency ratios could be used to measure how well ReWalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities. As of February 1, 2026, Return On Tangible Assets is expected to decline to -1.19. In addition to that, Return On Capital Employed is expected to decline to -0.91. At present, ReWalk Robotics' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.31, whereas Non Currrent Assets Other are projected to grow to (104.3 K).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kevin Esq | SINTX Technologies | 66 | |
| Nathaniel Grawey | Tenon Medical | N/A | |
| Jeff MD | Beyond Air | 59 | |
| Michael McNamara | In8bio Inc | N/A | |
| John Bishop | Lyra Therapeutics | 62 | |
| Alan Freidman | Transcode Therapeutics | N/A | |
| David Webster | Beyond Air | 58 | |
| Michael Marcroft | SINTX Technologies | N/A | |
| Yafit Tehila | Inspira Technologies Oxy | 45 | |
| Duncan Fatkin | Beyond Air | N/A | |
| John Jett | Beyond Air | N/A | |
| Robert Richard | Lyra Therapeutics | 67 | |
| Ryan Bock | SINTX Technologies | N/A | |
| Meshira Greenberg | Inspira Technologies Oxy | N/A | |
| Steve Moscaret | Tenon Medical | N/A | |
| Michel Roy | Sunshine Biopharma | 58 | |
| Zhixin Li | Pheton Holdings Ltd | 43 | |
| Daniel CPA | Beyond Air | 54 | |
| Andrew MD | Beyond Air | N/A | |
| Denton Drewell | Beyond Air | 39 | |
| Wyatt Giest | Tenon Medical | N/A | |
Management Performance
| Return On Equity | -1.28 | ||||
| Return On Asset | -0.32 |
ReWalk Robotics Leadership Team
Elected by the shareholders, the ReWalk Robotics' board of directors comprises two types of representatives: ReWalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ReWalk. The board's role is to monitor ReWalk Robotics' management team and ensure that shareholders' interests are well served. ReWalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ReWalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CoCEO Director | ||
| Michael Lawless, Chief Officer | ||
| William Grant, CoCEO President | ||
| Almog Adar, Chief Officer | ||
| Mark Grant, Director President | ||
| Miri Pariente, Regulatory Operations | ||
| Jeannine Lynch, Vice Strategy | ||
| Craig DPT, Vice Sales | ||
| Kathleen ODonnell, Vice Development | ||
| Charles Remsberg, Chief Officer | ||
| Judy Kula, Human Service |
ReWalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ReWalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.28 | ||||
| Return On Asset | -0.32 | ||||
| Profit Margin | (1.22) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 9.62 M | ||||
| Shares Outstanding | 18.29 M | ||||
| Shares Owned By Insiders | 1.75 % | ||||
| Shares Owned By Institutions | 4.73 % | ||||
| Number Of Shares Shorted | 1.73 M | ||||
| Price To Book | 0.87 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ReWalk Robotics is a strong investment it is important to analyze ReWalk Robotics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ReWalk Robotics' future performance. For an informed investment choice regarding ReWalk Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ReWalk Robotics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For information on how to trade ReWalk Stock refer to our How to Trade ReWalk Stock guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could ReWalk diversify its offerings? Factors like these will boost the valuation of ReWalk Robotics. Expected growth trajectory for ReWalk significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ReWalk Robotics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.91) | Revenue Per Share | Quarterly Revenue Growth 0.011 | Return On Assets | Return On Equity |
Investors evaluate ReWalk Robotics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating ReWalk Robotics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause ReWalk Robotics' market price to deviate significantly from intrinsic value.
Understanding that ReWalk Robotics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ReWalk Robotics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, ReWalk Robotics' market price signifies the transaction level at which participants voluntarily complete trades.